

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
Aflibercept-ayyh is an eye injection medication used to treat serious retinal conditions that can threaten your vision. This biosimilar version of the original aflibercept works by blocking specific proteins that cause abnormal blood vessel growth and fluid leakage in your eye. Think of it as a targeted treatment that helps restore the delicate balance your retina needs to function properly.
Aflibercept-ayyh is a biosimilar medication that belongs to a class of drugs called VEGF inhibitors. It's designed to work exactly like the original aflibercept (Eylea) but is produced by a different manufacturer. The "-ayyh" suffix helps distinguish it from other aflibercept products.
This medication is a laboratory-made protein that mimics your body's natural ability to control blood vessel growth. When injected directly into your eye, it helps stop the abnormal changes that can damage your retina and potentially lead to vision loss.
Your eye doctor will administer this treatment in their office using a very thin needle. The injection goes into the vitreous, which is the gel-like substance that fills the inside of your eye.
Aflibercept-ayyh treats several serious eye conditions that involve abnormal blood vessel growth or fluid accumulation in your retina. Your doctor might recommend this medication if you have wet age-related macular degeneration, diabetic macular edema, or certain types of retinal vein occlusion.
For wet age-related macular degeneration, the medication helps stop leaky blood vessels from growing under your macula. This condition primarily affects people over 50 and can cause rapid central vision loss if left untreated.
If you have diabetic macular edema, aflibercept-ayyh can reduce the swelling in your macula caused by diabetes. This swelling happens when high blood sugar damages the tiny blood vessels in your retina, causing them to leak fluid.
The medication also treats macular edema following retinal vein occlusion. This occurs when a blood clot blocks circulation in your retina, leading to fluid buildup and vision problems.
Aflibercept-ayyh works by blocking a protein called VEGF that promotes abnormal blood vessel growth in your eye. When VEGF levels are too high, it can cause blood vessels to grow where they shouldn't and leak fluid into your retina.
Think of VEGF as a signal that tells your body to create new blood vessels. While this process is helpful for healing wounds, it becomes problematic when it happens in your retina. The medication acts like a sponge, soaking up excess VEGF and preventing it from causing damage.
This is considered a moderately strong medication that targets the root cause of several retinal conditions. By controlling VEGF levels, it can help preserve your existing vision and sometimes even improve it.
The effects typically begin within days to weeks of your first injection. However, you'll likely need multiple treatments over time to maintain the benefits.
Your eye doctor will inject aflibercept-ayyh directly into your eye during an office visit. You don't take this medication at home, and there's no special preparation with food or drink required beforehand.
Before your injection, your doctor will clean your eye and surrounding area thoroughly. They'll use numbing drops to minimize discomfort during the procedure. The actual injection takes only a few seconds.
You should plan to have someone drive you home after your appointment. Your vision might be temporarily blurry, and your eye may feel slightly irritated for a few hours.
After the injection, you can eat and drink normally. However, avoid rubbing your treated eye and keep it clean according to your doctor's instructions. Most people can return to their regular activities the next day.
The duration of aflibercept-ayyh treatment varies depending on your specific condition and how well you respond to the medication. Many people need ongoing treatment for months or even years to maintain their vision improvement.
Initially, you'll likely receive injections every 4 to 8 weeks. Your doctor will monitor your progress closely and may adjust this schedule based on how your eye responds. Some people eventually need injections less frequently.
Your eye condition is typically chronic, meaning it requires long-term management rather than a cure. Think of these injections as similar to taking blood pressure medication - they help control your condition but need to be continued to maintain benefits.
Regular follow-up appointments are essential even if your vision seems stable. Your doctor will use special imaging tests to monitor changes in your retina that might not be noticeable to you yet.
Most people tolerate aflibercept-ayyh well, but like any medication, it can cause side effects. The most common ones are usually mild and temporary, while serious complications are rare but important to recognize.
Here are the side effects you might experience, starting with the most common ones:
These common side effects typically resolve within a day or two and don't require special treatment beyond following your doctor's aftercare instructions.
Less common but more concerning side effects include severe eye pain, sudden vision changes, or signs of infection such as increasing redness, discharge, or swelling. These warrant immediate medical attention.
Very rare but serious complications can include retinal detachment, severe inflammation inside the eye, or blood clots. While these occur in less than 1% of patients, they require emergency treatment to prevent permanent vision loss.
Some people may experience systemic side effects like headaches, high blood pressure, or blood clots elsewhere in the body. These are extremely rare but more likely in people with existing cardiovascular conditions.
Aflibercept-ayyh isn't suitable for everyone, and your doctor will carefully evaluate whether it's safe for you. People with active eye infections or severe inflammation in or around the eye should not receive this medication.
If you're allergic to aflibercept or any of its components, you shouldn't use this medication. Your doctor will review your allergy history before starting treatment.
People with certain cardiovascular conditions need special consideration. If you've recently had a stroke, heart attack, or blood clot, your doctor will weigh the benefits against potential risks before recommending treatment.
Pregnant women should generally avoid aflibercept-ayyh unless the benefits clearly outweigh the risks. The medication can potentially harm a developing baby, so effective contraception is important during treatment.
If you're breastfeeding, discuss this with your doctor. While it's unclear how much medication passes into breast milk, your doctor can help you make an informed decision about treatment timing.
Aflibercept-ayyh is available under the brand name Opuviz. This biosimilar version provides the same therapeutic benefits as the original aflibercept (Eylea) but may be available at a lower cost.
Your insurance coverage might differ between the original and biosimilar versions. Your doctor's office can help you understand which option works best with your insurance plan.
Both versions contain the same active ingredient and work identically in your eye. The choice between them often comes down to insurance coverage, availability, and cost considerations.
Several other medications can treat similar eye conditions if aflibercept-ayyh isn't right for you. Bevacizumab (Avastin) and ranibizumab (Lucentis) are other VEGF inhibitors that work in similar ways.
Brolucizumab (Beovu) is a newer option that may allow for longer intervals between injections. However, it carries a slightly higher risk of severe inflammation in some patients.
For certain conditions, your doctor might recommend laser treatments or photodynamic therapy instead of or in combination with eye injections. These alternatives work differently but can be effective for specific situations.
The best treatment depends on your specific condition, medical history, and personal preferences. Your eye doctor will help you understand all available options and their pros and cons.
Both aflibercept-ayyh and ranibizumab are effective treatments for retinal conditions, but they have some differences that might make one more suitable for you. Clinical studies show that aflibercept often allows for longer intervals between injections compared to ranibizumab.
Many patients receive aflibercept injections every 6 to 8 weeks after the initial treatment phase, while ranibizumab typically requires monthly injections. This means fewer doctor visits and procedures with aflibercept.
Both medications have similar effectiveness in preserving and improving vision. The choice often comes down to your specific condition, how you respond to treatment, and practical considerations like injection frequency.
Your doctor will consider factors like your lifestyle, travel schedule, and ability to attend frequent appointments when recommending between these options. Both are excellent choices with proven track records.
Is Aflibercept-ayyh Safe for People with Diabetes?
Yes, aflibercept-ayyh is generally safe for people with diabetes and is actually commonly used to treat diabetic macular edema. However, your doctor will monitor you carefully since diabetes can affect healing and increase infection risk.
People with diabetes should maintain good blood sugar control during treatment. Better diabetes management can improve your response to eye injections and reduce the risk of complications.
What Should I Do If I Accidentally Use Too Much Aflibercept-ayyh?
Since aflibercept-ayyh is administered by your doctor in a clinical setting, accidental overdose is extremely unlikely. The medication is pre-measured in single-use vials to prevent dosing errors.
If you're concerned about your injection or experience unusual symptoms after treatment, contact your eye doctor immediately. They can evaluate whether you need additional monitoring or treatment.
What Should I Do If I Miss a Dose of Aflibercept-ayyh?
If you miss a scheduled injection appointment, reschedule it as soon as possible. Don't wait until your next regularly scheduled appointment, as this could allow your condition to worsen.
Contact your doctor's office to arrange a new appointment. They may want to examine your eye before proceeding with the delayed injection to assess any changes in your condition.
When Can I Stop Taking Aflibercept-ayyh?
Never stop aflibercept-ayyh treatments without discussing it with your eye doctor first. Most retinal conditions require ongoing treatment to maintain vision improvements and prevent progression.
Your doctor will regularly assess whether you still need injections based on your eye exams and imaging tests. Some people may eventually need less frequent treatments, but complete discontinuation is usually not recommended.
Can I Drive After Receiving Aflibercept-ayyh?
You shouldn't drive immediately after your injection appointment. The numbing drops and temporary vision changes can affect your ability to drive safely.
Plan to have someone drive you home after your appointment. Most people can resume driving the next day once any temporary vision effects have resolved.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.